Literature DB >> 23487190

Neuropsychiatric disease in patients with periventricular heterotopia.

Andrew E Fry1, Michael P Kerr, Frances Gibbon, Peter D Turnpenny, Khalid Hamandi, Neil Stoodley, Stephen P Robertson, Daniela T Pilz.   

Abstract

Periventricular heterotopia (PH) is a disorder of neuronal migration. Previous clinical reports of PH have largely focused on the seizure-related and neurodevelopmental consequences of this condition. The authors report four unrelated individuals with PH, with particular emphasis on their behavioral and psychiatric morbidity. A review of the literature suggests that neuropsychiatric presentations are an underrecognized consequence of PH. Clinicians need to be alert to psychiatric complications associated with PH and related disorders of neuronal migration.

Entities:  

Mesh:

Year:  2013        PMID: 23487190     DOI: 10.1176/appi.neuropsych.11110336

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  10 in total

1.  Autism as a sequence: from heterochronic germinal cell divisions to abnormalities of cell migration and cortical dysplasias.

Authors:  Manuel F Casanova
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

2.  Neuronal Heterotopias Affect the Activities of Distant Brain Areas and Lead to Behavioral Deficits.

Authors:  Kazuhiro Ishii; Ken-ichiro Kubo; Toshihiro Endo; Keitaro Yoshida; Seico Benner; Yukiko Ito; Hidenori Aizawa; Michihiko Aramaki; Akihiro Yamanaka; Kohichi Tanaka; Norio Takata; Kenji F Tanaka; Masaru Mimura; Chiharu Tohyama; Masaki Kakeyama; Kazunori Nakajima
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

Review 3.  CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening.

Authors:  Tanya Chhibber; Sounak Bagchi; Behnaz Lahooti; Angela Verma; Abraham Al-Ahmad; Manash K Paul; Gurudutt Pendyala; Rahul Dev Jayant
Journal:  Drug Discov Today       Date:  2019-11-26       Impact factor: 7.851

4.  Generation of a multipurpose Prdm16 mouse allele by targeted gene trapping.

Authors:  Alexander Strassman; Frank Schnütgen; Qi Dai; Jennifer C Jones; Angela C Gomez; Lenore Pitstick; Nathan E Holton; Russell Moskal; Erin R Leslie; Harald von Melchner; David R Beier; Bryan C Bjork
Journal:  Dis Model Mech       Date:  2017-04-19       Impact factor: 5.758

5.  Neuropsychiatric symptoms and diagnosis of grey matter heterotopia: A case-based reflection.

Authors:  Gian Lippi
Journal:  S Afr J Psychiatr       Date:  2017-03-28       Impact factor: 1.550

Review 6.  Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.

Authors:  Glen E Kisby; Peter S Spencer
Journal:  Front Neurosci       Date:  2021-12-02       Impact factor: 4.677

Review 7.  Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening.

Authors:  Cuili Ma; Hwanwook Seong; Xiaowei Li; Xiao Yu; Shunliang Xu; Yujing Li
Journal:  Stem Cells Int       Date:  2022-08-25       Impact factor: 5.131

8.  Grey Matter Heterotopia and Criminal Responsibility in a Case of Personal Injury Defense.

Authors:  Antonietta Curci; Antonio Rampino
Journal:  Front Psychiatry       Date:  2020-04-01       Impact factor: 4.157

Review 9.  Linking Autism Risk Genes to Disruption of Cortical Development.

Authors:  Marta Garcia-Forn; Andrea Boitnott; Zeynep Akpinar; Silvia De Rubeis
Journal:  Cells       Date:  2020-11-18       Impact factor: 6.600

Review 10.  International consensus recommendations on the diagnostic work-up for malformations of cortical development.

Authors:  Renske Oegema; Tahsin Stefan Barakat; Martina Wilke; Katrien Stouffs; Dina Amrom; Eleonora Aronica; Nadia Bahi-Buisson; Valerio Conti; Andrew E Fry; Tobias Geis; David Gomez Andres; Elena Parrini; Ivana Pogledic; Edith Said; Doriette Soler; Luis M Valor; Maha S Zaki; Ghayda Mirzaa; William B Dobyns; Orly Reiner; Renzo Guerrini; Daniela T Pilz; Ute Hehr; Richard J Leventer; Anna C Jansen; Grazia M S Mancini; Nataliya Di Donato
Journal:  Nat Rev Neurol       Date:  2020-09-07       Impact factor: 42.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.